In patients on dialysis, cinacalcet reduced the rate of bone fracture by 16% to 29%, after accounting for patient characteristics and other factors, researchers report. Patients with kidney failure who are undergoing dialysis have an increased risk of bone fractures, and the risk of dying after a hip fracture in such a patient is double that of the general population. Unfortunately, none of the approved drugs for fracture prevention in osteoporosis in the general population are approved for use in patients on dialysis, and some are actually contraindicated.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1uydZZz
from Today's Healthcare News -- ScienceDaily http://ift.tt/1uydZZz
No comments:
Post a Comment